Clinical Trial

A Study to Evaluate the Accuracy of aTCI Model of Cipepofol in Patients With General Anesthesia During Elective Surgery

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2025 (before its estimated March 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a multi-center (each center independently conducts the study according to the same research protocol), randomized, and open-label clinical study. The main objective is to verify and optimize the accuracy of the target-controlled infusion model of cipepofol.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-13.
Status change: Not Yet Recruiting → Recruiting 2025-01-23
Trial Details
NCT Number NCT06740201
Lead Sponsor Haisco Pharmaceutical Group Co., Ltd.
Conditions Anesthesia
Enrollment 40 participants
Start Date 2025-01-06
Primary Completion 2025-03-30 (estimated)
Study Completion 2025-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-27